e-Therapeutics Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder

My aching to see the sunlight by the end of this tunnel leads me to this particular very great write-up about depression. Hope this information can help you too.

e-Therapeutics plc (AIM: ETX) announces that it has started a randomised double-blind controlled phase IIb trial of ETS6103 in major depressive disorder. The trial is evaluating ETS6103 as a second-line treatment for patients who have not responded adequately to first-line therapy with an SSRI (selective serot…e-Therapeutics Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder

Hoping I made your search and reading worthwhile. If not, you can look through the other related articles below. It would be my pleasure to hear from you so please leave a comment if you have any.

Here is a few more cool stuff regarding symptoms of depression

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s